Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Cancer Res. 2017 Apr 12;77(11):2927–2937. doi: 10.1158/0008-5472.CAN-16-3351

Table 1. Selected upregulated genes in CDS and eMCs expressing CIC-DUX4.

Gene name FC in tumor* FC in eMC* Gene product
Muc5ac 4663.1 ** mucin 5AC
Crh 3686.0 ** corticotropin releasing hormone
Zic1 2680.2 23.5 zinc finger protein
Etv4 2239.8 ** ets variant gene
Etv1 2023.7 39.1 ets variant gene
Col24a1 987.2 ** collagen, type XXIV, alpha 1
Fgfbp3 940.2 ** fibroblast growth factor binding protein
Etv5 611.2 42.0 ets variant gene
Col9a1 441.7 50.7 collagen, type IX, alpha 1
Col13a1 230.5 ** collagen, type XIII, alpha 1
Col9a3 192.6 45.8 collagen, type IX, alpha 3
Fli1 142.5 15.8 Friend leukemia integration 1
Col8a2 140.2 40.3 collagen, type VIII, alpha 2
Fmod 132.2 51.0 fibromodulin
Irf4 113.5 ** interferon regulatory factor 4
Cdkn2a 81.5 ** cyclin-dependent kinase inhibitor 2A
Kit 62.4 29.7 kit oncogene
Bcl2 41.4 19.6 B-cell leukemia/lymphoma 2
Col25a1 21.4 16.2 collagen, type XXV, alpha 1
Ccnd2 11.4 ** cyclin D2
Cdkn1c 7.3 *** cyclin-dependent kinase inhibitor 1C
Ccnd1 5.1 *** cyclin D1
Gpc3 5.1 *** glypican 3
Ets1 4.0 ** ets transcription factor
Col8a1 3.6 ** collagen, type VIII, alpha 1
Vcan 3.1 ** versican
*

fold change (FC) of gene expression versus eMCs with an empty vector

**

fold change >1.5 with p > 0.05

***

not upregulated

Genes upregulated in human CDS are underlined.